Nihon Kohden, a US market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, has appointed Dr Wilson P. Constantine the new chief executive officer of Nihon Kohden America.
Constantine, who joined the company’s US operations as chief operating officer in September 2014, was named CEO as part of a reorganization that will allow the company to remain ahead of the needs of the rapidly changing U.S. healthcare market. He succeeds Fumio Izumida, who led the company through solid double digit growth between 2010 and 2015.
“Wilson is a person who shares a passion to contribute to the advancement of medicine with new technologies, which is essential to the corporate philosophy of Nihon Kohden,” said Hirokazu Ogino, corporate director in charge of international operations for Nihon Kohden Corporation. “Upon joining our organization, he immediately began reshaping the corporate strategies based on his deep understanding of the unique needs of healthcare within the U.S. market. We believe he will demonstrate strong leadership to help the company achieve record growth in the coming months and years, and establish a robust foundation to provide better healthcare solutions to customers.”
“Our goal is to provide customers quality, innovative products with an exceptional experience, while also offering our people the opportunity to continue to grow in their roles and within the organization,” Constantine said. “By reorganizing, we are heeding the market’s call and will be able to better serve our customers and position the company for growth.”
